Fonstein Michael 4
4 · CLEVELAND BIOLABS INC · Filed Mar 20, 2012
Insider Transaction Report
Form 4
Fonstein Michael
DirectorCEO, President
Transactions
- Sale
Common Stock, par value $0.005 per share
2012-03-19$3.04/sh−35,601$108,241→ 1,188,400 total - Sale
Common Stock, par value $0.005 per share
2012-03-20$2.94/sh−20,000$58,896→ 1,168,400 total - Sale
Common Stock, par value $0.005 per share
2012-03-16$3.12/sh−44,399$138,636→ 1,224,001 total